Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
AI Guidelines for Physicians
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Please select the option that best describes you:
Topics:
Pulmonology
•
Critical Care
•
Hospital Medicine
Do you routinely start full dose anticoagulation in new onset atrial fibrillation in the ICU?
Answer from: at Community Practice
Yes. (Based on CHADS2 + Absence of absolute contraindications, i.e., active uncontrolled bleeding or coagulopathy.)
Sign in or Register to read more
Case-to-case basis based on the underlying cause and bleeding risk. I don't as readily in patients where it's driven by sepsis: Walkey et al., PMID 27487456
Sign in or Register to read more
17977
17979
Related Questions
Do you routinely check an Allen's test before placing a radial arterial line?
How do you approach caring for patients admitted with decompensated CHF, but who also exhibit hypotension and do not have overt signs of hypervolemia on exam?
Should long-acting subcutaneous insulin be started upfront in addition to regular insulin infusion for patients with diabetic ketoacidosis?
What are the logistical challenges and time constraints of implementing NIV for pre-oxygenation in emergency settings compared to oxygen masks?
What has been your stepwise approach to oxygenation, including when to consider the use of inhaled nitric oxide or epoprostenol, in refractory hypoxemia due to cardiogenic pulmonary edema in patients who are otherwise not ECMO candidates?
Does the use of NIV for pre-oxygenation delay the time to intubation?
Are there factors that would prompt you to consider the use of methylene blue in refractory septic shock?
What do you think about using conventional thoracic imaging methods (e.g., X-ray, CT, etc.) to determine if a pleural effusion is of adequate size to consider thoracentesis?
Would bag-mask ventilation with a PEEP valve be a reasonable alternative to NIV for pre-oxygenation prior to intubation in settings where NIV is not easily accessible?
What are some important considerations for use of ACE inhibition in scleroderma renal crisis patients who require dialysis?